Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
BWX Technologies, Inc. (NYSE: BWXT) generates news across defense, clean energy, nuclear medicine, space exploration and environmental restoration because of its focus on nuclear technologies and engineering services. Company announcements highlight work in both Government Operations and Commercial Operations, including naval nuclear component production, special materials processing, commercial nuclear components, field services, fuel and fuel handling, and medical-related activities.
News for BWXT often covers contracts and projects tied to the U.S. Naval Nuclear Propulsion Program and the U.S. government. For example, the company has reported a U.S. Naval Nuclear Propulsion Program contract for the manufacture of naval nuclear reactor fuel through its subsidiary Nuclear Fuel Services, Inc., which supplies fuel used in U.S. Navy submarines and aircraft carriers. Updates can also involve advanced fuel technologies such as TRISO nuclear fuel and programs like Project Pele, a microreactor prototype that uses Generation IV high-temperature gas-cooled reactor technology.
Commercial and international project news includes roles such as Owner’s Engineer for new nuclear build projects and collaboration with advanced reactor developers. BWXT has announced Owner’s Engineer services for Bulgaria’s New Build Kozloduy Nuclear Power Plant Units 7 and 8 as part of a consortium, and agreements with Rolls-Royce SMR involving nuclear steam generator design and potential future component supply for small modular reactors. These items illustrate how BWXT participates in large nuclear energy projects and advanced reactor supply chains.
Investors and observers can also expect BWXT news about quarterly financial results, non-GAAP performance metrics, capital markets transactions such as convertible senior notes offerings, and changes in senior leadership roles reported through press releases and Form 8-K filings. For ongoing insight into BWXT’s contracts, advanced nuclear initiatives and financial updates, this news page aggregates company disclosures and related coverage in one place.
NuScale Power is enhancing its manufacturing process at BWXT Canada Ltd.'s facility in Cambridge, Ontario, focusing on the fabrication of its NuScale Power Module™. This step is significant for the development of small modular reactor (SMR) technology and showcases NuScale's effort to establish a robust Canadian supply chain. BWXT Canada was engaged for an 18-month design contract, with further manufacturing agreements expected. The company emphasizes its capacity to source 80% of the plant components locally, aiming for Canadian deployment of the SMR technology by 2028.
BWX Technologies, Inc. (NYSE: BWXT) has secured a contract from Bruce Power worth approximately CA$40 million for the supply of four moderator heat exchangers. The contract will be implemented by BWXT Canada Ltd. at its Cambridge, Ontario facility, covering engineering and fabrication. Deliveries are planned for 2024 and 2025. This contract is expected to support a significant number of skilled jobs at BWXT’s Cambridge operations, contributing to reliable and non-emitting electricity generation in Ontario.
BWX Technologies reported Q2 2021 revenue of $505 million, unchanged from Q2 2020. Net income was $59.3 million or $0.62 per diluted share, down from $64.3 million or $0.67 per diluted share last year. The Nuclear Operations Group saw a 7% revenue decrease to $381 million, while the Nuclear Power Group's revenue surged 50% to $102 million. Despite cash from operations falling to $59.9 million from $162 million in Q2 2020, BWXT declared a quarterly dividend of $0.21 per share, payable on September 8, 2021.
BWX Technologies, Inc. (BWXT) is set to release its second quarter 2021 financial results on August 2, 2021, after the market closes. A conference call will follow at 5:00 p.m. EDT, allowing participants to join and access a supporting presentation online. BWXT, based in Lynchburg, Virginia, specializes in providing nuclear solutions across various sectors, employing approximately 6,700 individuals across 12 major sites in the U.S. and Canada. The company is involved in numerous joint ventures with the U.S. Department of Energy and NASA.
BWXT Medical Ltd. announced a long-term agreement with Boston Scientific to manufacture TheraSphere™ Y-90 Glass Microspheres, aimed at treating hepatocellular carcinoma (HCC). The deal includes substantial investment to automate production at BWXT's Ottawa facility, enhancing capacity to meet growing demand. This follows Boston Scientific's recent FDA PMA approval of TheraSphere, which increases patient access to this treatment. BWXT cautions that various risks may affect production and demand for TheraSphere.
BWX Technologies reported Q1 2021 revenue of $528 million, down 2.6% from $542 million in Q1 2020. Net income was $69.7 million ($0.73 per diluted share), a decrease from $75.5 million ($0.79 per diluted share) year-over-year. The Nuclear Operations Group faced a 5.1% revenue decline, while the Nuclear Power Group saw a 22% increase. The company generated $98.4 million in cash from operations, compared to a $6.4 million loss in Q1 2020, and declared a $0.21 dividend per share. BWXT reiterated 2021 guidance for revenue and non-GAAP EPS between $3.05 and $3.20.
BWX Technologies, Inc. (NYSE: BWXT) has enhanced its technical fellows initiative by selecting 25 new employees, recognizing their scientific and engineering contributions. The fellows, seen as senior technical leaders, will provide ongoing technical guidance and mentor future talent. This initiative aims to leverage expertise to strengthen workforce excellence and promote diversity in leadership. The program spans various business segments in the U.S. and Canada, focusing on areas like nuclear safety, automation, and engineering. BWXT is committed to fostering innovation and technical excellence.
BWX Technologies (NYSE: BWXT) has secured U.S. Naval Nuclear Propulsion Program contracts worth approximately $2.2 billion, including future options, for producing naval nuclear reactor components and fuel. This continues a long-standing partnership with the U.S. government spanning over 65 years. The contracts, initiated in 2021, will be fulfilled over an 8-year period across multiple facilities in Virginia, Ohio, and Indiana. The projects are vital for the Columbia and Virginia-class submarines, supporting U.S. strategic defense.
BWX Technologies, Inc. (BWXT) has announced a webcast to discuss its first quarter 2021 results on May 4, 2021, at 9:00 a.m. EDT. A press release detailing the results will follow after market close on May 3.
Listeners can join via www.bwxt.com/investors. Dial-in numbers for participants are (U.S.) 844-850-0542 and (International) 412-317-6014. A replay will be available on the BWXT website for a limited time.
BWX Technologies, Inc. (NYSE: BWXT) has successfully closed a $400 million offering of 4.125% senior notes due 2029. The Notes are guaranteed by its wholly owned subsidiaries. Proceeds will be utilized to redeem the outstanding 5.375% senior notes due 2026 and repay credit facility debt. Any remaining funds will be held in cash or short-term investments. The release includes forward-looking statements and cautions against undue reliance on them. Further risk factors can be found in BWXT's SEC filings.